Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Immunotherapy

Services, models of care, and interventions to improve access to cancer treatment for adults who are socially disadvantaged: A scoping review protocol

Tara C. Horrill, Amber Bourgeois, Max Kleijberg, Janice Linton, Kate Leahy, Kelli I. Stajduhar

published 26 Feb 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Comprehensive analysis of single cell and bulk data develops a promising prognostic signature for improving immunotherapy responses in ovarian cancer

Huanfei Ding, Bowen Hu, Ruixia Guo

published 12 Feb 2024

Loading metrics information...

Metrics unavailable. Please check back later.

A murine model to evaluate immunotherapy effectiveness for human Fanconi anemia-mutated acute myeloid leukemia

Tingting Huang, Bernice Leung, Yuyang Huang, Laura Price, Jiang Gui, Bonnie W. Lau

published 30 Jan 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy

Felix Peisen, Annika Gerken, Isabel Dahm, Konstantin Nikolaou, Thomas Eigentler, Teresa Amaral, Jan H. Moltz, Ahmed E. Othman, Sergios Gatidis

published 05 Jan 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma

Ren Li, Yang Chen, Biao Yang, Ziao Li, Shule Wang, Jianhang He, Zihan Zhou, Xuepeng Li, Jiayu Li, Yanqi Sun, Xiaolong Guo, Xiaogang Wang, Yongqiang Wu, Wenju Zhang, Geng Guo

published 05 Jan 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Molecular and clinical characterization of ICOS expression in breast cancer through large-scale transcriptome data

Peng Wang, Qin Zhang, Hengle Zhang, Jianqiang Shao, Hui Zhang, Zunyi Wang

published 21 Dec 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy

Adib Miraki Feriz, Fatemeh Bahraini, Arezou Khosrojerdi, Setareh Azarkar, Seyed Mehdi Sajjadi, Edris HosseiniGol, Mohammad Amin Honardoost, Samira Saghafi, Nicola Silvestris, Patrizia Leone, Hossein Safarpour, Vito Racanelli

published 14 Dec 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Longitudinal multi-functional analysis identified responses of T cells, B cells, and monocytes as hallmarks of immunotherapy tolerance in patients with merkel cell carcinoma

Quyuan Tao, Jia-xin Du, Shijing Zhang, Wenjia Lin, Yongxin Luo, Ying Liu, Jingyan Zeng, Xin-lin Chen

published 20 Nov 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Molecular classification of human papilloma virus-negative head and neck squamous cell carcinomas: Cell cycle-based classifier and prognostic signature

Hao Gu, Tingxuan Li, Narasimha M. Beeraka, Yufei Zheng, Xintan Zhang, Ruixia Song, Runze Zhou, Xiaoyan Wang, Olga Sukocheva, Ruitai Fan, Junqi Liu

published 30 Oct 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Safety and tolerability of weekly docetaxel plus nintedanib: A phase I trial after first-line chemotherapy failure in NSCLC

Virginie Westeel, Wolfgang Schuette, Thierry Urban, Dejan Radonjic, Ute von Wangenheim, Robert M. Lorence, Martin Reck

published 17 Oct 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors

Kaoru Fujikawa, Takuro Saito, Koji Kurose, Takashi Kojima, Takeru Funakoshi, Eiichi Sato, Kazuhiro Kakimi, Shinsuke Iida, Yuichiro Doki, Mikio Oka, Ryuzo Ueda, Hisashi Wada

published 20 Sep 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Identification of M2-like macrophage-related signature for predicting the prognosis, ecosystem and immunotherapy response in hepatocellular carcinoma

Qian Feng, Hongcheng Lu, Linquan Wu

published 19 Sep 2023

Loading metrics information...

Metrics unavailable. Please check back later.

An enhanced three-stage design with trend analysis for allergen immunotherapy trials

Xinyu Tang, Ronald L. Rabin, Lihan K. Yan

published 14 Sep 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Immunotherapy

You can change these options by clicking profile then "Alerts and Notifications"